Showing:
◈ medical devices×
We need to forge alliances to continue our global health leadership, writes the director of the Independent Commission on UK-EU Relations.
What will Brexit mean for UK dentistry?
06/04/2017
In the wake of last week’s triggering of Article 50, marking the formal start of Brexit negotiations, and the publication of the ‘Great Reform Bill’ it is a good time to ask what the effect will be on dentistry, both NHS and private.
Following the UK’s exit from the EU, the regulatory landscape for medical devices remains uncertain. Andrew Thompson, PhD, director of therapy research & analysis at GlobalData, explains what companies need to know.
In the latest Brexit step-down, many goods will now have indefinite CE mark recognition – but MHRA keeps 2028 and 2030 cut-offs for medical devices.
Adoption of Britain-only rival to EU’s CE designation postponed ‘indefinitely’, say ministers.
The UK should implement new EU medical device regulation into legislation post Brexit transition - Poll
29/03/2021
The new European Union (EU) Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR) are due to be implemented across the EU from May 2021.
Disruption to medical supplies at the UK border in the wake of Brexit will be ‘unavoidable’ warn experts.
The NHS and Brexit: What We Now Know
05/01/2023
Sam Bright examines the contribution of Brexit to our current healthcare crisis.
The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed its first certification body since the UK left the EU
03/10/2022
With the exception of the very lowest risk devices, manufacturers must apply to a UK approved body. Only after they have UKCA certification can their products be placed on the market in England, Wales and Scotland.
For almost 50 years, the NHS benefited from easy access to a large market, meaning it’s been first in the queue for the latest innovations. But what impact might Brexit have on medicines, medical devices and life sciences in the UK? Mark Dayan explains, in a blog that was first published in the BMJ on 26 February.
The impact of Brexit has only added fuel to the fire of severe challenges facing health and social care in the UK, warns the Nuffield Trust.
The Brexit predictions that came true, those that didn’t—and what we didn’t see coming - BMJ
03/08/2022
Six years after the referendum we can disentangle the evidence and judge the effects on health and care, says Richard Vize.
Businesses that make sporting goods, children’s toys, jewellery and medical goods have struggled the most with the border costs imposed by the UK’s decision to leave the EU.
Vaccines and blood products could be stockpiled ahead of a possible ‘no-deal’ Brexit, the health and social care secretary has confirmed.
Post-Brexit issues for the NHS
19/01/2022
There are a number of measures that the UK Government must take in order to address the challenges of leaving the EU's single market.
Nuffield Trust: Slow decisions and vague trade slogans leave NHS uncertain of post-Brexit future
20/12/2021
Our report published today looks at six key areas of health and social care that are being impacted by Brexit.
The Nuffield Trust think tank has published a new report on the impact of Brexit on the UK’s health and care services. The ongoing monitoring work, funded by the Health Foundation, covers the impact on the NHS and social care workforce, medicine and medical devices supply and the economic cost, and reveals negative effects across these areas.
Importing fresh food through the port of Dover would only be the Government’s third highest priority in the event of a no-deal Brexit later this year, it has emerged.
NI Brexit: Supply of medicines to NI fears as end of grace period looms - Health Minister Robin Swann admits he is concerned
22/04/2021
Northern Ireland’s Health Minister Robin Swann has voiced concern about the supply of medicines to the region as a result of a looming Brexit regulatory barrier to securing stock from the rest of the UK.
SCOTLAND'S two chief medical officers has issued a new warning of shortages to the supply of medicines in the event of a 'no deal' Brexit.
The chief pharmaceutical officer has warned that without mitigation, the supply of medicines and medical devices into Northern Ireland would be considered a "very high risk area".
There are supply issues with medical devices, fuel and food costs.
Medical devices in the UK will lack adequate safety standards until new post-Brexit regulations come into effect: Poll
22/03/2021
Verdict has conducted a poll to analyse whether medical devices in the UK will continue to have a high degree of safety until all new post-Brexit regulations come into effect by 2023.